ResearchPUBMEDApr 14
Scientists discovered that cells found in urine can be grown in the lab and used to diagnose genetic diseases. These urine cells come from a specific part of the kidney called the glomerulus, and they have special properties that make them useful for testing. This method could make genetic diagnosis easier because urine is simple to collect compared to other tissue samples.
WHY IT MATTERSIf your child needs genetic testing for a rare disorder, this research suggests urine samples could eventually replace more invasive procedures like blood draws or biopsies for molecular diagnosis.
ResearchPUBMEDApr 14
Scientists have discovered that certain rare genetic diseases are caused by mutations in genes that help cells copy their DNA. These genes normally produce proteins that untangle special twisted DNA structures called G-quadruplexes that get in the way during copying. When these proteins don't work properly, cells can't copy their DNA correctly, leading to problems like weak immune systems, slow growth, birth defects, and increased cancer risk.
WHY IT MATTERSUnderstanding which genes cause these G-quadruplex problems could help doctors diagnose patients with unexplained immunodeficiency, growth delays, or birth defects, and may eventually lead to targeted treatments for these currently untreatable conditions.
ResearchBIORXIVApr 14
Scientists created a new AI system called CoNVict that helps doctors figure out which genetic changes are actually causing rare diseases. Copy number variants (CNVs) are sections of DNA that are duplicated or missing, and they can cause genetic disorders, but it's hard to know which ones matter. This new tool uses artificial intelligence to automatically score and rank these genetic changes so doctors can focus on the ones most likely to be causing a patient's symptoms.
WHY IT MATTERSIf your child has unexplained developmental delays or birth defects and genetic testing found copy number variants, this AI tool could help doctors identify which variant is actually responsible for your child's condition, potentially speeding up diagnosis.
ResearchBIORXIVApr 14
Researchers studied how much money families and the healthcare system spend on KCNT1-related disorders, a rare genetic brain condition that causes severe seizures starting in early childhood. The study used information from both families caring for patients and medical records to understand the true financial costs. This is important because there are currently no approved treatments that can change the course of the disease, so families face lifelong expensive care.
WHY IT MATTERSIf you have a child with KCNT1-related epilepsy, this research documents the financial burden your family faces and provides evidence that could support insurance coverage decisions and funding for new treatments.
ResearchCLINICALTRIALSApr 14
Researchers completed a small study with 14 children who have rare diseases and their parents to test whether a social robot could help families cope better. The robot was designed to provide support and improve relationships between parents and children while reducing stress and worry. The study looked at whether families found the robot helpful and acceptable to use in their daily lives.
WHY IT MATTERSThis completed trial demonstrates a novel approach to family-centered support for rare disease patients—social robots may offer accessible emotional and relational support when specialized mental health resources for rare disease families are limited.
Clinical trialCLINICALTRIALSApr 14
Researchers at Mayo Clinic are looking for 6,000 people with rare kidney stone diseases caused by a single gene mutation to join a study. The study will identify which specific genes and genetic changes cause these kidney stones. By understanding the genetics behind these stones, scientists hope to develop better treatments in the future.
WHY IT MATTERSIf you have a rare monogenic kidney stone disease, this trial could help identify the genetic cause of your condition and accelerate development of targeted treatments — and you can enroll now.
Clinical trialCLINICALTRIALSApr 14
Researchers are testing a new medicine called pozelimab in young children ages 1 to 5 who have CHAPLE disease, a rare inherited condition that affects the stomach, intestines, heart, and blood vessels. This study is checking whether the medicine is safe and well-tolerated in this young age group. CHAPLE disease can cause serious symptoms, so finding safe treatments for young children is important.
WHY IT MATTERSThis is the first safety trial of pozelimab in very young children (ages 1-5) with CHAPLE disease, offering families of affected toddlers a potential treatment option when few alternatives exist for this life-threatening condition.
Clinical trialCLINICALTRIALSApr 14
Researchers are recruiting 7,000 cancer patients to test a new way of detecting cancer that comes back after treatment. By analyzing blood, tissue, and other body fluids for traces of cancer DNA, doctors hope to catch cancer earlier and help patients stay cancer-free longer. This study includes many types of cancer and will help doctors decide on the best treatment plans.
WHY IT MATTERSThis trial is now actively recruiting patients with various cancer types at a major Canadian cancer center, offering access to cutting-edge molecular residual disease testing that could detect cancer recurrence months before traditional imaging scans.
PolicyRSSApr 13
The FDA sent reminders to over 2,200 companies and research groups telling them they must share their clinical trial results on a public website called ClinicalTrials.gov. This is a requirement, not optional. The FDA is making sure that information about how medical treatments work—whether they help patients or cause problems—gets shared publicly so everyone can see the results.
WHY IT MATTERSWhen companies hide negative trial results, patients may not know the full picture about whether a treatment actually works, which could affect decisions about whether to participate in a trial or use a medication.
ResearchPUBMEDApr 13
This article helps doctors who read medical images understand rare tumors that grow in women's reproductive organs. These tumors are uncommon, affecting fewer than 6 out of every 100,000 people each year, which makes them hard to diagnose and treat. The article explains what these tumors look like on imaging scans and how doctors can better identify them to help plan treatment.
WHY IT MATTERSIf you have been diagnosed with an uncommon gynecological tumor, radiologists who understand these rare conditions are better equipped to provide accurate imaging reports that guide your treatment decisions.
ResearchBIORXIVApr 13
A research study about how parents cope when their children have rare diseases and doctors can't quickly figure out what's wrong was withdrawn from a scientific website. The authors submitted the study with false information, so it is no longer available for other researchers to read or use.
WHY IT MATTERSThis withdrawal highlights the importance of verifying research quality and integrity — families relying on studies about rare disease diagnosis need accurate, trustworthy information to guide their own experiences.
ResearchBIORXIVApr 12
Scientists created animal models (using fish and mice) that mimic DeSanto-Shinawi Syndrome, a rare genetic disorder caused by mutations in the WAC gene. These animal models showed symptoms similar to what patients experience, including developmental delays, intellectual disability, autism-like behaviors, and seizures. This research helps scientists understand how WAC gene mutations cause these symptoms and could lead to better treatments in the future.
WHY IT MATTERSFor the first time, researchers have created animal models that reproduce the key symptoms of DeSanto-Shinawi Syndrome, which could accelerate the discovery of why patients develop autism, seizures, and developmental delays—and potentially identify new treatment targets.
ResearchPUBMEDApr 12
Researchers in Canada studied 715 patients with rare diseases who had their entire genome sequenced (a test that reads all of a person's genetic code). The study found that genome sequencing helped doctors in many ways: it confirmed diagnoses in some patients, changed how doctors treated 36% of patients, found new research opportunities, and identified genetic information that relatives should know about. The test also helped doctors avoid unnecessary tests in 88% of cases.
WHY IT MATTERSIf you have an undiagnosed rare disease, this research shows that whole genome sequencing can help your doctor find answers and change your treatment plan — and it may also reveal important genetic information for your family members.
ResearchPUBMEDApr 11
Researchers at Boston Children's Hospital created a new system that automatically re-examines genetic test results from patients with rare diseases as doctors learn more about genes and diseases. Many patients get genetic tests but don't get answers the first time. This new system helps find answers by looking at old test results again without waiting for doctors to manually review each one.
WHY IT MATTERSIf you or your child had genetic testing that didn't find a diagnosis, this system could identify the cause of your rare disease by re-analyzing your existing test results as medical knowledge improves—potentially saving you years of diagnostic searching.
ResearchPUBMEDApr 10
This study talked to 10 parents in South Africa whose children have rare diseases to understand what challenges they face as caregivers. The parents said they struggle with stress, worry about their children's health, and sometimes feel tired and sad. The researchers want doctors and hospitals to better understand what caregivers go through so they can offer more help and support.
WHY IT MATTERSIf you're caring for a child with a rare disease, this research validates that your struggles are real and documented — and shows healthcare systems need to provide better caregiver support services.
PolicyBIORXIVApr 10
Researchers created a standard naming and classification system for rare diseases to help doctors and scientists share information more easily across different countries. Right now, rare diseases aren't well organized in medical databases, which makes it hard to collect data and help patients. This new system aims to fix that problem so patients can be recognized and tracked better worldwide.
WHY IT MATTERSStandardized rare disease terminology means your diagnosis is more likely to be recognized consistently across different hospitals and countries, improving your chances of being included in research studies and getting accurate care.
ResearchPUBMEDApr 10
Doctors from around the world created a network called the International Neuroblastoma Risk Group to share information about neuroblastoma, a type of cancer that starts in nerve cells. They combined data from over 25,000 patients to help researchers understand the disease better and develop better treatment plans. This teamwork model shows how rare cancer research can be improved when hospitals and countries work together.
WHY IT MATTERSPatients with neuroblastoma now benefit from standardized treatment approaches and risk classifications developed through this international collaboration, which means more consistent and potentially better care regardless of where they receive treatment.
Clinical trialCLINICALTRIALSApr 9
Researchers at Columbia University are looking for 106 children and young adults with Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy Type 3 (SMA Type 3) to join a study. The study will use special sensors and technology to track how people walk and move in their daily lives over a long period of time. The goal is to find new ways to measure how these diseases are progressing so doctors can better understand and treat them.
WHY IT MATTERSThis trial is now actively recruiting participants with DMD and SMA Type 3, offering a chance to contribute to developing better measurement tools that could help doctors track disease progression and evaluate future treatments more accurately.
ResearchPUBMEDApr 9
Researchers studied how digital tools like telemedicine and online apps can help patients with phenylketonuria (PKU), a rare genetic disorder affecting how the body processes certain proteins. They surveyed PKU patients and doctors in Spain, Germany, and Ireland to understand what digital tools work best for managing this condition that requires regular check-ups and careful monitoring. The study shows that digital health tools became more important during COVID-19 and can help patients stay connected with their doctors and learn more about their condition.
WHY IT MATTERSIf you have PKU or care for someone with PKU, this research identifies which digital tools patients actually want and need to manage their condition better and communicate with their healthcare team.
Clinical trialUNITERAREApr 9
Researchers are testing a new medicine called difelikefalin to see if it's safe and works well for teenagers on kidney dialysis who have severe itching. Itching is a common problem for dialysis patients that can really affect their quality of life. This study will check whether the medicine helps reduce itching and what side effects it might cause.
WHY IT MATTERSThis is the first trial testing difelikefalin specifically in adolescents on hemodialysis with moderate-to-severe pruritus — a condition that significantly impacts quality of life but has limited treatment options for younger patients.